Literature DB >> 8707120

Thrombotic vascular risk factors in inflammatory bowel disease.

M Hudson1, A Chitolie, R A Hutton, M S Smith, R E Pounder, A J Wakefield.   

Abstract

BACKGROUND: Thrombosis may be an important effector mechanism in the pathogenesis of Crohn's disease.
METHODS: This study therefore investigated the prevalence of independent thrombotic risk factors (factor VII coagulant activity, lipoprotein (a), fibrinogen, plasma triglycerides, and smoking) in patients with Crohn's disease, ulcerative colitis, and normal controls.
RESULTS: In Crohn's disease (n = 75), the mean plasma VII:C, lipoprotein (a) and fibrinogen concentrations were significantly greater than in the normal population (n = 85). In ulcerative colitis (n = 35), only the mean factor VII:C concentration was significantly higher than normal. Ninety three per cent of patients with Crohn's disease and 86% of those with ulcerative colitis had at least one risk factor for thrombotic vascular disease, compared with 61% of the normal population (p < 0.001).
CONCLUSIONS: In many young patients with inflammatory bowel disease, plasma concentrations of these prothrombotic factors were in excess of the limits that are regarded as posing an increased risk for the development of occlusive vascular disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8707120      PMCID: PMC1383156          DOI: 10.1136/gut.38.5.733

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  33 in total

1.  [Rapid physiological coagulation method in determination of fibrinogen].

Authors:  A CLAUSS
Journal:  Acta Haematol       Date:  1957-04       Impact factor: 2.195

2.  A simple index of Crohn's-disease activity.

Authors:  R F Harvey; J M Bradshaw
Journal:  Lancet       Date:  1980-03-08       Impact factor: 79.321

3.  Relation between extent of coronary artery disease and blood viscosity.

Authors:  G D Lowe; M M Drummond; A R Lorimer; I Hutton; C D Forbes; C R Prentice; J C Barbenel
Journal:  Br Med J       Date:  1980-03-08

4.  Genetic and environmental determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heart disease.

Authors:  A Lane; J K Cruickshank; J Mitchell; A Henderson; S Humphries; F Green
Journal:  Atherosclerosis       Date:  1992-05       Impact factor: 5.162

5.  Immunohistochemical study of tissue factor expression in normal intestine and idiopathic inflammatory bowel disease.

Authors:  L More; R Sim; M Hudson; A P Dhillon; R Pounder; A J Wakefield
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

6.  Inherited disorders of coagulation appear to protect against inflammatory bowel disease.

Authors:  N P Thompson; A J Wakefield; R E Pounder
Journal:  Gastroenterology       Date:  1995-04       Impact factor: 22.682

7.  Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis.

Authors:  M Orholm; L Iselius; T I Sørensen; P Munkholm; E Langholz; V Binder
Journal:  BMJ       Date:  1993-01-02

8.  Evidence for activation of coagulation in Crohn's disease.

Authors:  M Hudson; R A Hutton; A J Wakefield; A M Sawyerr; R E Pounder
Journal:  Blood Coagul Fibrinolysis       Date:  1992-12       Impact factor: 1.276

9.  Mucosal capillary thrombi in rectal biopsies.

Authors:  A P Dhillon; A Anthony; R Sim; A J Wakefield; E A Sankey; M Hudson; M C Allison; R E Pounder
Journal:  Histopathology       Date:  1992-08       Impact factor: 5.087

10.  Effects of cigarette smoking on the ultrastructure of rat thoracic aorta and its ability to produce prostacyclin.

Authors:  R M Pittilo; I J Mackie; P M Rowles; S J Machin; N Woolf
Journal:  Thromb Haemost       Date:  1982-10-29       Impact factor: 5.249

View more
  23 in total

1.  Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications.

Authors:  N Mahmud; A Molloy; J McPartlin; R Corbally; A S Whitehead; J M Scott; D G Weir
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Hyperhomocysteinemia in Greek patients with inflammatory bowel disease.

Authors:  I E Koutroubakis; E Dilaveraki; I G Vlachonikolis; E Vardas; G Vrentzos; E Ganotakis; I A Mouzas; A Gravanis; D Emmanouel; E A Kouroumalis
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

Review 3.  Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades.

Authors:  Livija Deban; Carmen Correale; Stefania Vetrano; Alberto Malesci; Silvio Danese
Journal:  Am J Pathol       Date:  2008-05-05       Impact factor: 4.307

Review 4.  Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.

Authors:  Franco Scaldaferri; Stefano Lancellotti; Marco Pizzoferrato; Raimondo De Cristofaro
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

5.  Assessment of anti-prothrombin antibodies in thrombosis complicating inflammatory bowel diseases.

Authors:  Simone Saibeni; Maria J Etchevers; Dolors Tassies; Julián Panés; Joan C Reverter; Silvio Danese; Josep M Piqué; Savino Bruno; Maurizio Vecchi; Antonio Gasbarrini; Miquel Sans
Journal:  Int J Colorectal Dis       Date:  2013-04-16       Impact factor: 2.571

6.  Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel disease.

Authors:  I E Koutroubakis; E Petinaki; E Anagnostopoulou; H Kritikos; I A Mouzas; E A Kouroumalis; O N Manousos
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

Review 7.  Venous thrombosis and prothrombotic factors in inflammatory bowel disease.

Authors:  Fernando Magro; João-Bruno Soares; Dália Fernandes
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

8.  Relationship and significance between anti-beta2-glycoprotein I antibodies and platelet activation state in patients with ulcerative colitis.

Authors:  Yan-Hang Gao; Pu-Jun Gao; Chun-Guang Wang; Xiao-Cong Wang; Yun-Feng Piao
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

9.  Assessment of thrombophilic abnormalities during the active state of inflammatory bowel disease.

Authors:  Maha M Maher; Somaya H Soloma
Journal:  Saudi J Gastroenterol       Date:  2008-10       Impact factor: 2.485

10.  Coagulation parameters in inflammatory bowel disease.

Authors:  Can Dolapcioglu; Aliye Soylu; Tulin Kendir; Ali Tuzun Ince; Hatice Dolapcioglu; Sevim Purisa; Cengiz Bolukbas; Haci Mehmet Sokmen; Remzi Dalay; Oya Ovunc
Journal:  Int J Clin Exp Med       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.